British Society for Haematology. Listening. Learning. Leading British Society for Haematology. Listening. Learning. Leading

The Global Haematology Special Interest Group (SIG) workplan was created following a stakeholder workshop held in 2016, with representatives from the BSH and haematologists from lower-and-middle income countries (LMIC). One stream of our work was a two year pilot scheme where selected BSH speakers visited LMIC haematology meetings and established links with haematology societies. In 2017 two of our UK representatives spoke at conferences in Ghana and Kenya.

Get Involved

Plenary Speaker Scheme 2019 - Sri Lanka (Deadline: 1 August 2019)

Applications are invited the British Society for Haematology Plenary Speaker Programme 2019. We aim to form international partnerships between the BSH and haematology societies in low and middle-income countries, to share knowledge and expertise.

The BSH has funds available to pay for a BSH member (post-trainee) to attend The Sri Lanka College of Haematologists (SLCH) Annual Academic Sessions of the SLCH 2019, in Colombo on 18 and 19 September 2019.

The Sri Lanka College of Haematologists would like a specialist in the area of Paroxysmal Nocturnal Haemoglobinuria (PNH) to give the BSH Plenary Lecture. They request that the plenary speaker discuss therapeutic advances in PNH and diagnostic aspects of PNH.

We hope that the plenary speaker programme will encourage ongoing exchange of expertise, and we therefore encourage applicants to use this opportunity to collaborate on, for example, co-authored evidence-based treatment guidelines adapted for haematology in low and middle income settings. We also encourage applicants to collaborate on research or publication of studies to improve evidence and treatment in the low and middle income country setting.

SLCH are seeking a plenary speaker willing to provide the local haematologists with an opportunity to discuss grey areas in diagnosis & management of PNH, and who could assist in improving diagnostic aspects of PNH in Sri Lanka. Their longer-term aims are to improve care of the PNH patients in Sri Lanka, and to develop diagnostic and therapeutic guidelines for PNH.

The BSH will cover economy return international flights, accommodation, required visas and subsistence for the speaker. BSH is not able to cover the costs of vaccinations and advises that the volunteer seeks professional advice about required vaccinations.

The closing date for applications is Thursday 1 August 2019.

Applications will be reviewed by a panel and applicants will be notified of the outcome within 2 weeks of the closing date. Members of the BSH Global Haematology special interest group work closely with our international partner societies and the BSH Plenary Speakers to provide support during both planning and evaluation stages. To assess the success of this initiative we will also request written feedback from you after the event. Details of this will be sent nearer the time.

The application form can be downloaded here.

We look forward to hearing from you. If you have any queries, please contact

Task Force Member - Plenary Speaker Scheme (Deadline 31 August 2019)

The BSH Global Haematology Special Interest Group (SIG) are seeking a third Task Force member to collaborate on the BSH Plenary Speaker Scheme.

BSH is funding plenary speakers for haematology and transfusion conferences in low-to-middle income countries (LMIC). The aim is to foster partnerships between the BSH and other haematology societies to share knowledge and expertise. During the pilot scheme in 2017/18, BSH selected speakers for conferences in Ghana, Kenya, Egypt and Thailand, with a number of collaborative projects subsequently arising in education, research, and capacity building. Following these successes, BSH is expanding the scheme for 2019/20.

The SIG is looking for a trainee or consultant haematologist to join the two existing Task Force members to help with selecting applicant LMIC societies and speakers, to liaise between them, and to contribute to providing feedback on the scheme to the BSH.

The time commitment is small; a few hours per month. The Task Force collaborates predominantly through email and phone calls, and the wider SIG meets quarterly.

Please send an email briefly detailing your interest in joining the Task Force and any relevant experience, along with CV, to

Deadline: 31 August 2019

About the Scheme

Making Links, Creating Networks

The initial phases of this project involved mapping out and making contacts with active haematology and transfusion societies in LMICs worldwide.

A search was undertaken for active haematology societies in LMICs in Africa, Europe, the Middle East and Asia.

Attendees from LMICs at the 2016 BSH international congress were contacted, and respondents asked about active haematology societies in their region. Internet searches were performed and haematologists and transfusion specialists in large teaching hospitals in LMICs were contacted.

LMIC haematology societies were shortlisted for our 2017 pilot scheme based on pre-defined criteria, and the Ghanaian Society of Haematology (GHASH) and the Haematology and Oncology Society of Africa (HOSA) were invited to take part

Matching Speakers to Societies

The 2017 HOSA meeting was titled ‘Haematology in Africa: Beyond Benign; More than Malignant’. They requested a specialist in lymphoma to speak on  both diagnosis and management.

The theme of the 2017 GHASH meeting was ‘Anaemia in the Young and Old: Differentials and Challenges’. They requested a speaker who could talk about unusual causes of anaemia and also give advice on developing their laboratory facilities and enrolling in external Quality Assurance schemes.

The committee then advertised for UK consultants with the relevant sub-speciality experience and an interest in ongoing collaboration with our haematology colleagues in LMICs. They were short-listed and interviews were held in June 2017.


Dr Maadh Aldouri was selected to represent the BSH at the HOSA conference in Nairobi, Kenya in August 2017. His plenary lecture on lymphoma in a low resource setting was well received.

At the conference he also had the opportunity to take part in a sickle cell neonatal screening workshop, and following the conference he visited Agha Khan University and Nairobi University Hospitals to meet with their haematologists and trainees.


Dr Humayun Ahmad represented the BSH at the GHASH conference in Accra, Ghana in November 2017. In addition to giving the plenary talk on the differential causes of anaemia, he also provided tutorials for trainees and staff. 

As part of an ongoing collaboration, arrangements are being made for clinical attachments in the UK for Ghanaian haematology trainees.


A further round of Plenary Speakers is planned for 2018. The scheme is undergoing in depth qualitative feedback and evaluation to assess short-term and longer-term potential impact in fostering BSH-LMIC collaborations particularly in teaching, research and clinical practice and guidelines.